Correlation Between Cns Pharmaceuticals and VectivBio Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and VectivBio Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and VectivBio Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and VectivBio Holding AG, you can compare the effects of market volatilities on Cns Pharmaceuticals and VectivBio Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of VectivBio Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and VectivBio Holding.

Diversification Opportunities for Cns Pharmaceuticals and VectivBio Holding

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cns and VectivBio is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and VectivBio Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VectivBio Holding and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with VectivBio Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VectivBio Holding has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and VectivBio Holding go up and down completely randomly.

Pair Corralation between Cns Pharmaceuticals and VectivBio Holding

Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the VectivBio Holding. In addition to that, Cns Pharmaceuticals is 3.57 times more volatile than VectivBio Holding AG. It trades about -0.05 of its total potential returns per unit of risk. VectivBio Holding AG is currently generating about 0.14 per unit of volatility. If you would invest  822.00  in VectivBio Holding AG on August 23, 2024 and sell it today you would earn a total of  863.00  from holding VectivBio Holding AG or generate 104.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy30.44%
ValuesDaily Returns

Cns Pharmaceuticals  vs.  VectivBio Holding AG

 Performance 
       Timeline  
Cns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
VectivBio Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Cns Pharmaceuticals and VectivBio Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cns Pharmaceuticals and VectivBio Holding

The main advantage of trading using opposite Cns Pharmaceuticals and VectivBio Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, VectivBio Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VectivBio Holding will offset losses from the drop in VectivBio Holding's long position.
The idea behind Cns Pharmaceuticals and VectivBio Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account